Adjusted EBITDA was $44.3 million for Q1 compared to $91.1 million for the first quarter of 2025
Reported or proposed issue Drug or supplement interactions Evidence source Mechanism-based theory Known or theoretical
Once consistent supply is available through the pharmacies' wholesaler, Hims & Hers plans to make branded options available to customers, expanding the offering beyond the current oral medication kits and compounded GLP-1 injectable medications
In the case of a GLP-1 receptor agonist like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), microdosing refers to taking lower than the labeled dose
However, the exact functional significance of aberrantly glycosylated IGF-1R is not clear
5 If there are clinical concerns about aspiration risk, consider a minimally invasive gastroscopy to inspect the stomach